Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluids

Nanomedicine: Nanotechnology, Biology, and Medicine

Volumn 10, Issue 5, 2014, Pages e879-e888

  Fan, Jia ^a,b   Niu, Shiwen ^a,f   Dong, Ailian ^a,g   Shi, Jian ^a   Wu, Hung Jen ^b   Fine, Daniel H ^b   Tian, Yaping ^c   Zhou, Chunxi ^d   Liu, Xuewu ^b   Sun, Tong ^b   Anderson, Gregory J ^e   Ferrari, Mauro ^b,h   Nie, Guangjun ^a   Hu, Ye ^b,h   Zhao, Yuliang ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d BRUKER DALTONIK GMBH   (Germany)

^e ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^f JILIN UNIVERSITY   (China)

^g THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^h WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Biomarker discovery; Hepcidin; MALDI TOF MS; Nanoporous silica film; Peptide

Indexed keywords

BIOMARKERS; COST EFFECTIVENESS; DIAGNOSIS; EXTRACTION; NANOPORES; PATHOLOGY; SILICA; THIN FILMS;

BIO-MARKER DISCOVERY; CAPILLARY ADSORPTIONS; CLINICAL PRACTICES; HEALTHY VOLUNTEERS; HEPCIDIN; MALDI TOF MS; NANOPOROUS SILICA FILMS; PEPTIDE EXTRACTION;

PEPTIDES;

HEPCIDIN; NANOFILM; SILICON DIOXIDE; ARTIFICIAL MEMBRANE; BIOLOGICAL MARKER; PEPTIDE;

ADSORPTION; ADULT; ARTICLE; BODY FLUID; CLINICAL PRACTICE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; EXTRACTION; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; INFLAMMATION; MALE; NANOFABRICATION; NANOPORE; NORMAL HUMAN; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN IMMOBILIZATION; QUANTITATIVE ANALYSIS; STATIC ELECTRICITY; SURFACE CHARGE; ARTIFICIAL MEMBRANE; CHEMISTRY; MASS SPECTROMETRY;

BIOLOGICAL MARKERS; BODY FLUIDS; HEPCIDINS; HUMANS; MEMBRANES, ARTIFICIAL; NANOPORES; PEPTIDES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84903537752     PISSN: 15499634     EISSN: 15499642     Source Type: Journal    
DOI: 10.1016/j.nano.2014.02.005     Document Type: Article

References (30)

1. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788.
2. Jordan J.B., Poppe L., Haniu M., Arvedson T., Syed R., Li V., et al. Hepcidin revisited, disulfide connectivity, dynamics, and structure. J Biol Chem 2009, 284:24155-24167.
3. Nemeth E., Ganz T. The role of hepcidin in iron metabolism. Acta Haematol 2009, 122:78-86.
4. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
5. Theurl I., Aigner E., Theurl M., Nairz M., Seifert M., Schroll A., et al. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009, 113:5277-5286.
6. Koliaraki V., Marinou M., Vassilakopoulos T.P., Vavourakis E., Tsochatzis E., Pangalis G.A., et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One 2009, 4:e4581.
7. Olbina G., Pastorino X., Girelli D., O'brien K.O., Nemeth E., Ganz T., et al. Immunoassay for human hepcidin in blood. Blood 2008, 112:1311.
8. Murphy A.T., Witcher D.R., Luan P., Wroblewski V.J. Quantitation of hepcidin from human and mouse serum using liquid chromatography tandem mass spectrometry. Blood 2007, 110:1048-1054.
9. Tomosugi N., Kawabata H., Wakatabe R., Higuchi M., Yamaya H., Umehara H., et al. Detection of serum hepcidin in renal failure and inflammation by using proteinchip system. Blood 2006, 108:1381-1387.
10. Anderson D.S., Heeney M.M., Roth U., Menzel C., Fleming M.D., Steen H. High-throughput matrix-assisted laser desorption ionization-time-of-flight mass spectrometry method for quantification of hepcidin in human urine. Anal Chem 2010, 82:1551-1555.
11. Li H., Rose M.J., Tran L., Zhang J., Miranda L.P., James C.A., et al. Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS/MS. J Pharmacol Toxicol Methods 2009, 59:171-180.
12. Ward D.G., Roberts K., Stonelake P., Goon P., Zampronio C.G., Martin A., et al. SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard. Proteome Sci 2008, 6:1-13.
13. Swinkels D.W., Girelli D., Laarakkers C., Kroot J., Campostrini N., Kemna E.H.J.M., et al. Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry. PLoS One 2008, 3:e2706.
14. Galesloot T.E., Vermeulen S.H., Geurts-Moespot A.J., Klaver S.M., Kroot J.J., van Tienoven D., et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011, 117:e218-e225.
15. De Domenico I., Nemeth E., Nelson J.M., Phillips J.D., Ajioka R.S., Kay M.S., et al. The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 2008, 8:146-156.
16. Nemeth E., Preza G.C., Jung C.L., Kaplan J., Waring A.J., Ganz T. The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study. Blood 2006, 107:328-333.
17. Bansal S.S., Abbate V., Bomford A., Halket J.M., Macdougall I.C., Thein S.L., et al. Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer. Rapid Commun Mass Spectrom 2010, 24:1251-1259.
18. Gay M.C.L., Mullaney I., Trinder D., Olynyk J.K., Trengove R.D. Quantitative assay of urinary hepcidin using MALDI-TOF mass spectrometry. Anal Methods 2010, 2:268-274.
19. Bansal S.S., Halket J.M., Fusova J., Bomford A., Simpson R.J., Vasavda N., et al. Quantification of hepcidin using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 2009, 23:1531-1542.
20. Hu Y., Bouamrani A., Tasciotti E., Li L., Liu X., Ferrari M. Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight protein. ACS Nano 2010, 4:439-451.
21. Barrett E.P., Joyner L.G., Halenda P.P. The determination of pore volume and area distributions in porous substances. I. Computations from nitrogen isotherms. J Am Chem Soc 1951, 73:373-380.
22. Zhao D., Yang P., Melosh N., Feng J., Chmelka B.F., Stucky G.D. Continuous mesoporous silica films with highly ordered large pore structures. Adv Mater 1998, 10:1380-1385.
23. Vinu A., Murugesan V., Hartmann M. Adsorption of lysozyme over mesoporous molecular sieves MCM-41 and SBA-15: influence of pH and aluminum incorporation. J Phys Chem B 2004, 108:7323-7330.
24. Qin H., Gao P., Wang F., Zhao L., Zhu J., Wang A., et al. Highly efficient extraction of serum peptides by ordered mesoporous carbon. Angew Chem Int Ed 2011, 50:12218-12221.
25. Hu L., Zhou H., Li Y., Sun S., Guo L., Ye M., et al. Profiling of endogenous serum phosphorylated peptides by titanium (IV) immobilized mesoporous silica particles enrichment and MALDI-TOFMS detection. Anal Chem 2009, 81:94-104.
26. Tian R., Zhang H., Ye M., Jiang X., Hu L., Li X., et al. Selective extraction of peptides from human plasma by highly ordered mesoporous silica particles for peptidome analysis. Angew Chem Int Ed 2007, 46:962-965.
27. Stromme M., Brohede U., Atluri R., Garcia-Bennett A.E. Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2009, 1:140-148.
28. Popat A., Liu J., Hu Q., Kennedy M., Peters B., Lu G.Q., et al. Adsorption and release of biocides with mesoporous silica nanoparticles. Nanoscale 2012, 4:970-975.
29. Hartmann M., Streb C. Selective oxidation of indole by chloroperoxidase immobilized on the mesoporous molecular sieve SBA-15. J Porous Mat 2006, 13:347-352.
30. Patwardhan S.V., Emami F.S., Berry R.J., Jones S.E., Naik R.R., Deschaume O., et al. Chemistry of aqueous silica nanoparticle surfaces and the mechanism of selective peptide adsorption. J Am Chem Soc 2012, 134:6244-6256.